- Home
- RLAY vs SHLS Comparison
RLAY vs SHLS Comparison
Compare RLAY & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | SHLS |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RLAY | SHLS |
|---|---|---|
| Price | $9.15 | $9.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | ★ $15.75 | $9.40 |
| AVG Volume (30 Days) | 2.5M | ★ 4.1M |
| Earning Date | 02-24-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | $8,355,000.00 | ★ $433,993,000.00 |
| Revenue This Year | $19.96 | $20.59 |
| Revenue Next Year | N/A | $18.69 |
| P/E Ratio | ★ N/A | $53.97 |
| Revenue Growth | N/A | ★ 2.68 |
| 52 Week Low | $1.78 | $2.71 |
| 52 Week High | $9.25 | $11.36 |
Technical Indicators
Market Signals| Indicator | RLAY | SHLS |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 53.41 |
| Support Level | $8.08 | $9.31 |
| Resistance Level | $9.25 | $10.76 |
| Average True Range (ATR) | 0.67 | 0.71 |
| MACD | 0.12 | 0.02 |
| Stochastic Oscillator | 83.02 | 52.45 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.